Article
The landscape of pharmacogenetic testing in a US managed care population
14 Apr 2020
Abstract excerpt
PURPOSE: Little is known about how many insured patients receive pharmacogenetic testing. We describe trends of single-gene pharmacogenetic testing in a US managed care population, and demographic and clinical characteristics of patients who received a test. METHODS: We leveraged a random sample of nearly 11 million patients from a data set of paid medical and pharmacy claims to identify patients with at least...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
